18-31074864-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BS1_Supporting
The NM_024422.6(DSC2):c.1707C>A(p.Asp569Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000868 in 1,613,784 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_024422.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DSC2 | NM_024422.6 | c.1707C>A | p.Asp569Glu | missense_variant | Exon 12 of 16 | ENST00000280904.11 | NP_077740.1 | |
DSC2 | NM_004949.5 | c.1707C>A | p.Asp569Glu | missense_variant | Exon 12 of 17 | NP_004940.1 | ||
DSC2 | NM_001406506.1 | c.1278C>A | p.Asp426Glu | missense_variant | Exon 12 of 16 | NP_001393435.1 | ||
DSC2 | NM_001406507.1 | c.1278C>A | p.Asp426Glu | missense_variant | Exon 12 of 17 | NP_001393436.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DSC2 | ENST00000280904.11 | c.1707C>A | p.Asp569Glu | missense_variant | Exon 12 of 16 | 1 | NM_024422.6 | ENSP00000280904.6 | ||
DSC2 | ENST00000251081.8 | c.1707C>A | p.Asp569Glu | missense_variant | Exon 12 of 17 | 1 | ENSP00000251081.6 | |||
DSC2 | ENST00000648081.1 | c.1278C>A | p.Asp426Glu | missense_variant | Exon 13 of 17 | ENSP00000497441.1 | ||||
DSC2 | ENST00000682357.1 | c.1278C>A | p.Asp426Glu | missense_variant | Exon 12 of 16 | ENSP00000507826.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152070Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 250896Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135618
GnomAD4 exome AF: 0.0000937 AC: 137AN: 1461714Hom.: 0 Cov.: 32 AF XY: 0.0000935 AC XY: 68AN XY: 727150
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152070Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74260
ClinVar
Submissions by phenotype
not provided Uncertain:3
- -
The DSC2 c.1707C>A; p.Asp569Glu variant (rs201517977) is reported in the literature in an individual in a WES cohort study without corresponding cardiomyopathy phenotype (Hou 2020). This variant is also reported in ClinVar (Variation ID: 191621) and is found in non-Finnish European population with an allele frequency of 0.01% (11/113396 alleles) in the Genome Aggregation Database. The aspartic acid at codon 569 is highly conserved, but computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.485). Due to limited information, the clinical significance of the p.Asp569Glu variant is uncertain at this time. -
Has not been previously published in association with arrhythmia phenotype to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31980526, 23861362) -
Arrhythmogenic right ventricular dysplasia 11 Uncertain:1
This sequence change replaces aspartic acid, which is acidic and polar, with glutamic acid, which is acidic and polar, at codon 569 of the DSC2 protein (p.Asp569Glu). This variant is present in population databases (rs201517977, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with DSC2-related conditions. ClinVar contains an entry for this variant (Variation ID: 191621). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt DSC2 protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiomyopathy Uncertain:1
This missense variant replaces aspartic acid with glutamic acid at codon 569 of the DSC2 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with arrhythmogenic right ventricular cardiomyopathy (Hou et al., 2018). This variant has also been identified in 11/250896 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Familial isolated arrhythmogenic right ventricular dysplasia Uncertain:1
This missense variant replaces aspartic acid with glutamic acid at codon 569 of the DSC2 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with arrhythmogenic right ventricular cardiomyopathy (Hou et al., 2018). This variant has also been identified in 11/250896 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at